[Federal Register Volume 82, Number 12 (Thursday, January 19, 2017)]
[Notices]
[Page 6645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01103]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Noramco, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before March 20, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated her 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
12, 2016, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 
19801-4417 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Marihuana.............................       7360  I
Codeine-N-oxide.......................       9053  I
Dihydromorphine.......................       9145  I
Hydromorphinol........................       9301  I
Morphine-N-oxide......................       9307  I
Amphetamine...........................       1100  II
Methylphenidate.......................       1724  II
Phenylacetone.........................       8501  II
Codeine...............................       9050  II
Dihydrocodeine........................       9120  II
Oxycodone.............................       9143  II
Hydromorphone.........................       9150  II
Hydrocodone...........................       9193  II
Morphine..............................       9300  II
Oripavine.............................       9330  II
Thebaine..............................       9333  II
Opium extracts........................       9610  II
Opium fluid extract...................       9620  II
Opium tincture........................       9630  II
Opium, powdered.......................       9639  II
Opium, granulated.....................       9640  II
Oxymorphone...........................       9652  II
Noroxymorphone........................       9668  II
Tapentadol............................       9780  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. In reference to 
drug code 7360, the company plans to manufacture a synthetic version of 
cannabidiol in bulk for sale to its customers, who are final dosage 
form manufacturers. No other activity for this drug code is authorized 
for this registration.

    Dated: January 11, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-01103 Filed 1-18-17; 8:45 am]
 BILLING CODE 4410-09-P